Effexor withdrawal side effects

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Effexor Withdrawal Side Effects

Effexor (venlafaxine) is a commonly prescribed antidepressant that belongs to the serotonin-norepinephrine reuptake inhibitor (SNRI) class. While effective for treating depression and anxiety, discontinuing Effexor can lead to withdrawal symptoms, which can be challenging for patients.

Common Withdrawal Symptoms

Physical Symptoms

Patients discontinuing Effexor often experience a range of physical withdrawal symptoms. These can include dizziness, headaches, nausea, and fatigue. Such symptoms are frequently reported and can significantly impact daily functioning 25.

Neurological Symptoms

Neurological symptoms are also prevalent during Effexor withdrawal. These can manifest as "brain zaps" (electric shock sensations in the brain), tremors, and sensory disturbances. These symptoms can be particularly distressing and may contribute to a sense of disorientation and discomfort 24.

Psychological Symptoms

Psychological withdrawal symptoms are another critical aspect of Effexor discontinuation. Patients may experience heightened anxiety, irritability, mood swings, and depressive symptoms. These psychological effects can be severe and may mimic the original symptoms for which Effexor was prescribed, complicating the withdrawal process 25.

Severe Withdrawal Reactions

Stroke-like Symptoms

In rare cases, Effexor withdrawal can present with severe symptoms that resemble a stroke. This phenomenon has been documented and highlights the potential seriousness of discontinuation effects. Such symptoms necessitate immediate medical attention to rule out actual cerebrovascular events and to manage the withdrawal process safely .

Case Reports and Clinical Observations

Several case reports and clinical observations have highlighted the intensity of withdrawal reactions associated with Effexor. These reports underscore the importance of gradual tapering under medical supervision to mitigate severe withdrawal effects .

Conclusion

Effexor withdrawal can lead to a variety of physical, neurological, and psychological symptoms, some of which can be severe. Gradual tapering and medical supervision are crucial to managing these withdrawal effects effectively. Understanding the potential side effects can help patients and healthcare providers prepare for and navigate the discontinuation process more safely.

Sources and full results

Most relevant research papers on this topic

Selective Immediate Hypersensitivity to Clavulanic Acid

Selective immediate hypersensitivity to clavulanic acid may occur in patients with known hypersensitivity to venlafaxine, a common antidepressant.

2003·

21citations

·N. Raison-Peyron et al.

Methylphenidate as a Possible Cause of Thrombocytopenia

1. Muth EA, Haskins JT, Moyer JA, Husbands GE, Nielsen ST, Sigg EB. Antidepressant biochemical profile of the novel bicyclic compound Wy45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 1986; 35:4493-7. 2. Package insert. Effexor (venlafaxine). Wyeth-Ayerst. www.wyeth.com. (accessed 2003 May 22). 3. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45. 4. Haddad PM, Devarajan S, Dursun SM. Antidepressant discontinuation (withdrawal) symptoms presenting as “stroke.” J Psychopharmacol 2001;15:139-41. 5. Johnson H, Bouman WP, Lawton J. Withdrawal reaction associated with venlafaxine (letter). BMJ 1998;317:787.

2003·

10citations

·A. Kuperman et al.

Analyse this

Anti-depressant drugs may increase suicidal thoughts in children, triggering renewed concerns about their safety and effectiveness in treating depression.

2003·

1citation

·Vicki Brower

GAMMA-HYDROXYBUTYRIC ACID FOR TREATMENT OF ALCOHOL WITHDRAWAL SYNDROME

GHB treatment (50 mg/kg) effectively reduces alcohol withdrawal symptoms in alcoholics, with the only side-effect being dizziness.

RCTHighly Cited

1989·

256citations

·L. Gallimberti et al.

Transient Exposure of Endothelial Cells to Doxorubicin Leads to Long-Lasting Vascular Endothelial Growth Factor Receptor 2 Downregulation

Short-term exposure to Doxorubicin leads to long-lasting VEGFR2 downregulation in endothelial cells, causing permanent damage and senescence.

In Vitro Study

2022·

18citations

·Silvia Graziani et al.

Venlafaxine hydrochloride (EffexorTM) relieves thermal hyperalgesia in rats with an experimental mononeuropathy 1 1 This study was presented in abstract form at the 1995 Annual Meeting of the American Society of Anesthesiologists in Atlanta, Georgia.

Venlafaxine hydrochloride (Effexor) effectively relieves thermal hyperalgesia in rats with neuropathic pain due to chronic constriction injury of the sciatic nerve, without causing sedation.

RCTAnimal Study

1996·

69citations

·E. Lang et al.

The PsyTAR dataset: From patients generated narratives to a corpus of adverse drug events and effectiveness of psychiatric medications

The PsyTAR dataset identifies adverse drug events and drug effectiveness in psychiatric medications from patient reviews, providing valuable information for drug safety and effectiveness research.

Observational Study

2019·

39citations

·M. Zolnoori et al.

A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?

U.K. and U.S. guidelines on antidepressant withdrawal are out of date, as evidence shows withdrawal symptoms can last for more than two weeks and may lead to misdiagnosis and unnecessary prescriptions.

Systematic ReviewHighly Cited

2019·

269citations

·J. Davies et al.

A depot neuroleptic withdrawal study neurological effects

Depot neuroleptics effectively prevent relapse and rehospitalization in chronic schizophrenic patients, but may cause neurological side effects during withdrawal.

RCTRigorous Journal

2004·

12citations

·B. Wistedt et al.

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review

Pharmacovigilance systems in low-resource settings should be strengthened and regulatory authorities should coordinate in assessing the benefit-harm balance of new analgesics.

Systematic Review

2018·

18citations

·I. Onakpoya et al.

Try another search

what is a binary star system

what epoch are we in

treatments for heart attack

are gmos safe

martian temperature

order of all planets